CannaPharmaRX, Inc.
CPMD
$0.0044
-$0.0001-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3,245.73% | -- | -- | -- | 127.78% |
| Gross Profit | -2,510.67% | -- | -- | -- | -127.78% |
| SG&A Expenses | 79.83% | -76.00% | -65.53% | -49.03% | -125.88% |
| Depreciation & Amortization | 9.16% | -- | -13.24% | -68.66% | -231.11% |
| Other Operating Expenses | -49.00% | -- | -- | -- | -3.47% |
| Total Operating Expenses | 383.80% | 21.36% | -61.18% | 52.03% | -122.04% |
| Operating Income | -315.46% | 25.41% | 61.18% | -48.45% | 122.04% |
| Income Before Tax | -149.58% | 133.38% | 385.29% | -729.36% | 307.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -149.58% | 133.38% | 385.29% | -729.36% | 307.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.58% | 133.38% | 385.29% | -729.36% | 307.31% |
| EBIT | -315.46% | 25.41% | 61.18% | -48.45% | 122.04% |
| EBITDA | -275.09% | 4.79% | 68.17% | -46.42% | 127.18% |
| EPS Basic | -126.54% | 115.79% | 228.57% | -595.83% | 246.53% |
| Normalized Basic EPS | -975.00% | 116.67% | 273.68% | -1,005.00% | 104.71% |
| EPS Diluted | -126.54% | 115.79% | 228.57% | -595.83% | 246.53% |
| Normalized Diluted EPS | -975.00% | 116.67% | 273.68% | -1,005.00% | 104.71% |
| Average Basic Shares Outstanding | 85.27% | 124.50% | 119.58% | 19.68% | 41.39% |
| Average Diluted Shares Outstanding | 85.27% | 124.50% | 119.58% | 19.68% | 41.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |